Skip to main content
. 2019 Sep 23;63(10):e00873-19. doi: 10.1128/AAC.00873-19

TABLE 5.

Urine recovery of FEP and TAZ

Drug, period,a and statistic Mild
Moderate
Severe
Impairment (n = 6) Control (n = 6) Impairment (n = 5) Control (n = 6) Impairment (n = 6) Control (n = 6)
FEP
    0–2 h
        Mean 620.8 730.5 308.4 762.9
        SD 191.0 164.4 252.0 159.4
    0–4 h
        Mean 1,198.4 1,354.1 659.2 1,446.0
        SD 471.1 243.9 362.3 183.6
    0–8 h
        Mean 1,666.5 1,816.9 1,047.5 1,773.9
        SD 539.0 262.0 419.3 272.4
    0–12 h
        Mean 1,848.8 1,962.4 1,295.5 1,865.7
        SD 576.4 301.3 541.3 301.2
    0–24 h
        Mean 1,977.6 2,030.4 1,524.5 1,914.8 359.1 1,950.2
        SD 560.4 330.4 559.7 308.3 99.3 276.1
    0–48 h
        Mean 1,981.1 2,030.4 1,562.8 1,914.8 438.7 1,950.2
        SD 563.0 330.4 563.3 308.3 102.6 276.1
TAZ
    0–2 h
        Mean 1,053.1 1,086.6 557.8 1,168.9
        SD 279.0 255.1 321.9 221.3
    0–4 h
        Mean 1,656.7 1,558.3 1,021.2 1,683.7
        SD 575.0 219.7 403.0 258.6
    0–8 h
        Mean 1,874.6 1,778.2 1,293.0 1,776.6
        SD 622.3 269.6 408.0 269.3
    0–12 h
        Mean 1,907.2 1,791.0 1,365.1 1,776.6
        SD 639.3 291.0 412.9 269.3
    0–24 h
        Mean 1,907.2 1,791.0 1,365.1 1,776.6 296.1 1,842.9
        SD 639.3 291.0 412.9 269.3 53.2 174.8
    0–48 h
        Mean 1,907.2 1,791.0 1,365.1 1,776.6 296.1 1,842.9
        SD 639.3 291.0 412.9 269.3 53.2 174.8
a

Postdose times are indicated.